Pfizer Shares Bounce Between Bull And Bear
21245
Pfizer Inc.&#39;s shares continued to rebound Wednesday, gaining 4 percent during the day&#39;s trading, as industry analysts continued to sort out the most recent studies involving its Celebrex drug.
421539
This morning, Pfizer (nyse: PFE - news - people ) announced that it had received data from two long-term studies in using its arthritis drug Celebrex to prevent cancer.
438179
Shares of Pfizer Inc. slipped on Wednesday, following reports that a study had likened the companyâs Bextra arthritis drug to Merck&#39;s Vioxx in terms of its cardiovascular risks.
214732
Investors will digest reports from Pfizer and Capital One, among others.
502501
The Dow Jones industrial average fell  on Friday after Pfizer Inc. PFE.N shares opened nearly 19  percent down on trial data for its popular arthritis drug  Celebrex that showed increased risk of heart attack.
362559
Drug investors may be wishing they could pop two pills and feel better in the morning. The latest headache hit last week when Pfizer joined the rash of drug companies announcing problems with their products.
547638
U.S. stocks bounced higher on Tuesday  as battered insurers such as Marsh & McLennan Cos. MMC.N  gained on increased confidence of a quick resolution to New  York Attorney General Eliot Spitzer's probe of the industry.
259614
NEW YORK - Shares of pharmaceutical company Pfizer Inc. fell sharply in early trading after the firm reported an increased risk of heart disease for patients taking its Celebrex painkiller and arthritis drug.
561772
NEW YORK  - Drugs giant Pfizer Inc.&#39;s stock fell on a report that new prescriptions for its blockbuster pain medication Celebrex slumped 56 percent last week.
141438
European shares traded sideways on Wednesday but banks were a bright spot as Britain&#39;s HBOS rallied on relief it would not be wading into a bidding war for domestic peer Abbey.
303018
Pfizer Inc.  on Monday boosted  its quarterly dividend 21 percent after the surprise failure of  its most important experimental drug caused a sell- off in its  shares, and gave its new chief executive additional duties as  chairman.
387898
Pfizer Inc, Novartis AG and Wyeth all  saw quarterly earnings hit by charges on Thursday, while Eli  Lilly and Co exceeded Wall Street expectations as third-quarter  sales of several of its drugs outpaced analysts' estimates.
194747
Shares in Pfizer Inc  fell around 14 percent in European and pre-opening U.S. trade on Monday after the world's biggest drugmaker scrapped development of its most important experimental medicine.
693310
The Pfizer painkillers Celebrex and Bextra experienced a jump in sales immediately after rival Merck&#39;s Vioxx was pulled from the market in late September, but the gains appear to be short
437095
Shares of Pfizer Inc. dropped 11% to $25.80 on Friday, after the company said a long-term study revealed that its Celebrex painkiller drug increased the risk of heart problems.
225639
Pfizer Inc. PFE.N , the world's  largest drug company, on Wednesday said fourth-quarter earnings  rose, helped by strong sales of cholesterol treatment Lipitor  and other medicines.
421295
U.S. stocks rose on Monday as several major corporate deals pointed to optimism about the economy, outweighing sharp losses by blue-chip Pfizer Inc.  after the world's No. 1 drug company dropped a key experimental product.